arrow
S

Sharon J. Diskin

Mass General Brigham
H指数:46
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Surface and global proteomics identify ROR2 and other proteins as potentially actionable immunotherapeutic targets in osteosarcoma

表面和全局蛋白质组学鉴定ROR2和其他蛋白质为骨肉瘤中潜在的可行免疫治疗靶点

2026-08-010
PRE
Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors

生殖系致病变异影响儿童中枢神经系统肿瘤的体细胞改变和患者结局

2025-11-210
OAAI
Late effects after high-risk neuroblastoma (LEAHRN): a multicentre, cross-sectional cohort study from the Children's Oncology Group

高危神经母细胞瘤后的迟发效应(LEAHRN):一项来自儿童肿瘤组的 multicentre, cross-sectional cohort study

2025-09-250
PRE
The Open Pediatric Cancer Project

开放儿科癌症项目

2025-09-020
OAAI
The Non-Coding Regulatory Variant rs2863002 at chr11p11.2 Increases Neuroblastoma Risk by Affecting HSD17B12 Expression and Lipid Metabolism

chr11p11.2位点的非编码调控变异rs2863002通过影响HSD17B12的表达和脂质代谢来增加神经母细胞瘤的风险。

2025-06-010
OAAI
INTEGRATED GERMLINE AND SOMATIC PROFILING OF PEDIATRIC BRAIN TUMORS REVEALS INCIDENTAL FINDINGS AND NOVEL TUMOR BIOLOGY
2024-06-180
OAAI
Aberrant CLK1 splicing is a key dependency factor in pediatric high-grade gliomas
2024-03-220
PRE
Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival
2023-09-0912
OA
Integrative Genomic Analyses Identify LncRNA Regulatory Networks across Pediatric Leukemias and Solid Tumors

整合基因组分析确定跨小儿白血病和实体瘤的LncRNA调控网络

2023-08-163
PRE
OpenPBTA: The Open Pediatric Brain Tumor Atlas
2023-07-019
OAAI
PIONEER: harnessing multi-omics data to enhance immunotherapeutic target discovery and development
2023-04-040
PRE
The children's brain tumor network (CBTN)-Accelerating research in pediatric central nervous system tumors through collaboration and open science
2023-01-0130
OAAI
Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants

在没有ATRX突变的情况下,小儿高级别神经胶质瘤中端粒 (ALT) 的替代延长可能会发生,并且在致病性种系错配修复 (MMR) 变体的患者中富集。

2022-12-2010
OAAI